The Bioscience Association of Maine strongly opposes LD 1422, “An Act To Allow Maine Residents To Personally Import Medications as Permitted under the Federal Food, Drug, and Cosmetic Act”. This legislation, if passed, will present a great risk to the public health of Maine residents and will also open the State of Maine to additional costly and unnecessary litigation. BAM is of the opinion that the legislation outlined in LD 1422 is misguided and we feel inappropriately addresses the issue it purportedly seeks to remedy. Read full statement here
Related Posts
Maine’s first mobile biolab starts tour of rural schools in Fort Kent
FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...
UMaine Augusta’s $1.75M medical lab training facility doubles student capacity
Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...
UNE receives grant to research state-threatened animal
The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...